![](/img/cover-not-exists.png)
Rosiglitazone Reduces Plasma Levels of Inflammatory and Hemostatic Biomarkers and Improves Global Endothelial Function in Habitual Heavy Smokers Without Diabetes Mellitus or Metabolic Syndrome
I-Chih Chen, Ting-Hsing Chao, Wei-Chuan Tsai, Yi-Heng LiVolume:
109
Year:
2010
Language:
english
DOI:
10.1016/s0929-6646(10)60031-9
File:
PDF, 215 KB
english, 2010